EJMO. 2017; 1(2): 115-117 | DOI: 10.14744/ejmo.2017.10820

Sunitinib-Associated Acute Pancreatitis: A Case Report

Melek Karakurt Eryilmaz¹, Fatma Yalcin Musri¹, Derya Kivrak Salim¹, Gokhan Tazegul², Hasan Senol Coskun^1
1Department of Medical Oncology, Akdeniz University Faculty of Medicine, Antalya, Turkey, ²Department of Internal Medicine, Akdeniz University Faculty of Medicine, Antalya, Turkey,

Sunitinib is a multikinase inhibitor used for the treatment of metastatic renal cell carcinoma. Acute pancreatitis associated with sunitinib is rare. Presently described is a case of a 79-year-old man with metastatic renal cell carcinoma who developed acute pancreatitis following the initiation sunitinib treatment. The development of acute pancreatitis secondary to sunitinib should be considered in patients presenting with abdominal pain after the administration of sunitinib.

---

Cite This Article

Karakurt Eryilmaz M, Yalcin Musri F, Kivrak Salim D, Tazegul G, Coskun H. Sunitinib-Associated Acute Pancreatitis: A Case Report. EJMO. 2017; 1(2): 115-117

Corresponding Author: Melek Karakurt Eryilmaz

Full Text PDF PDF Download